Skip to main content

Balchem Corporation (BCPC)

NASDAQ Stock Market Basic Materials Chemicals - SpecialtyView data quality →
56.6Fair

ValueMarkers Composite Index

Top 61%#17,339 of 44,707
Fairly Valued

10% above intrinsic value ($159)

UndervaluedFair ValueOvervalued
Piotroski
9/9
Strong
Beneish
-2.41
Low Risk
Altman
9.63
Safe
DCF Value
$159
Overvalued
ROIC
11.0%
Adequate
P/E
36.8
Growth
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Balchem Corporation (BCPC) — VMCI valuation read

Balchem Corporation (BCPC) carries a VMCI composite of 57/100, 7 points above the Basic Materials sector median of 50. Among mid-cap names, that gap places BCPC in the top third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The BCPC insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads BCPC trades at 24.0x earnings, 33% above the Basic Materials median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Basic Materials 12.0x. Quality: ROIC of 14.0% sits 4.0pp above the Basic Materials median (10.0%). Risk: net debt to EBITDA of 2.6x is the rate-sensitivity line to watch, the line to track on Balchem Corporation's next 10-Q.

BCPC rose 0.7% over the trailing 7 days, with a -15.6% read on a 30-day basis.

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.

CEO: Theodore Lee Harris1,379 employeesUSwww.balchem.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in BCPC’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.